A single center experience with mycophenolate mofetil in the prevention of renal allograft rejection

Transplant Proc. 1996 Dec;28(6):3110-1.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Double-Blind Method
  • Europe
  • Female
  • Follow-Up Studies
  • Graft Rejection / mortality
  • Graft Rejection / prevention & control*
  • Graft Survival
  • Histocompatibility Testing
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Male
  • Middle Aged
  • Muromonab-CD3 / therapeutic use
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Placebos
  • Postoperative Complications
  • Survival Rate
  • Time Factors
  • Transplantation, Homologous

Substances

  • Immunosuppressive Agents
  • Muromonab-CD3
  • Placebos
  • Mycophenolic Acid